MedPath

A DEXA Clinical Study to Evaluate the Osteointegrative Potential of Trabecular Titanium™

Not Applicable
Completed
Conditions
Primary Total Hip Replacement
Interventions
Device: Delta TT acetabular cup
Registration Number
NCT02635581
Lead Sponsor
Limacorporate S.p.a
Brief Summary

The purpose of this clinical trial is to evaluate the osteointegrative potential of the Trabecular TitaniumTM and to measure the pattern of changing in bone mineral density (BMD) around an uncemented acetabular cup, manufactured in Trabecular Titanium™ , during 60 months after surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
84
Inclusion Criteria
  • BMI< 40 kg/m2
  • Indication suitable to the implantation of Delta TT acetabular cup (First implant)
  • Idiopathic osteoarthritis
  • Avascular necrosis
  • Post-traumatic arthritis
  • Presence of sufficient periacetabular bone stock
  • Ability to understand the investigation, cooperate with the investigational procedure and willing to return to the hospital for the required post-operative follow-ups
  • Written informed consent
Exclusion Criteria
  • Patients found unsuitable for an implantation of Delta TT acetabular cup (Revision)
  • Patients aged 76 or older
  • Haemophilic disease
  • Femur neck fracture
  • Insulin Dependent Diabetes Mellitus (IDDM)
  • Severe kidney failure (grade 4)
  • Not responder Hypo- or Hyperthyroidism
  • Paget's disease
  • Tumours
  • Active or suspicious infections
  • Neurosensory deficits or neuromuscular diseases
  • Severe and impairing vascular diseases
  • Known incompatibility or allergy to products materials
  • Woman with pregnancy or childbearing capacity or breast-feeding
  • Subjects already enrolled in other clinical trials

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
DELTA TTDelta TT acetabular cup-
Primary Outcome Measures
NameTimeMethod
The percentage change of the bone mineral density (BMD) around the acetabular cups with DEXA scanFrom baseline to 5 year Follow-up
Secondary Outcome Measures
NameTimeMethod
Harris Hip Score (HHS)From baseline to 5 year Follow-up
SF-36 scoreFrom baseline to 5 year Follow-up

Trial Locations

Locations (4)

Azienda Ospedaliero-Universitaria di Ferrara, Arcispedale S. Anna

🇮🇹

Cona, Ferrara, Italy

Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Dipartimento di Ortopedia, Traumatologia e Riabilitazione, Ospedale CTO, Clinica II

🇮🇹

Torino, Italy

Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Dipartimento di Ortopedia, Traumatologia e Riabilitazione, Ospedale CTO, Clinica I

🇮🇹

Torino, Italy

Azienda Ospedaliero-Universitaria di Udine, Santa Maria della Misericordia

🇮🇹

Udine, Italy

© Copyright 2025. All Rights Reserved by MedPath